Source Natural Foods & Herbal Supplements Ltd
Incorporated in 1998, Source Natural Foods
and Herbal Supplements Ltd provides Ayurveda, Health & Dietary Supplements and Food Products[1]
- Market Cap ₹ 56.8 Cr.
- Current Price ₹ 88.2
- High / Low ₹ 115 / 74.5
- Stock P/E 22.5
- Book Value ₹ 28.2
- Dividend Yield 0.00 %
- ROCE 18.8 %
- ROE 12.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.55 | 3.76 | 4.54 | 6.54 | 10.93 | 15.94 | 10.84 | 12.81 | 13.59 | 24.88 | 21.53 | 19.79 | 27.32 | |
1.79 | 3.16 | 4.12 | 5.83 | 9.97 | 14.12 | 9.43 | 11.22 | 11.20 | 20.71 | 17.68 | 16.24 | 22.76 | |
Operating Profit | -0.24 | 0.60 | 0.42 | 0.71 | 0.96 | 1.82 | 1.41 | 1.59 | 2.39 | 4.17 | 3.85 | 3.55 | 4.56 |
OPM % | -15.48% | 15.96% | 9.25% | 10.86% | 8.78% | 11.42% | 13.01% | 12.41% | 17.59% | 16.76% | 17.88% | 17.94% | 16.69% |
-0.17 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.02 | 0.33 | 0.49 | 0.01 | 0.01 | |
Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.07 | 0.24 | 0.20 | 0.23 | 0.10 | 0.24 | 0.39 | 0.21 |
Depreciation | 0.24 | 0.25 | 0.26 | 0.54 | 0.49 | 0.35 | 0.35 | 0.34 | 0.34 | 0.37 | 0.42 | 0.43 | 0.89 |
Profit before tax | -0.65 | 0.35 | 0.17 | 0.16 | 0.47 | 1.41 | 0.83 | 1.05 | 1.84 | 4.03 | 3.68 | 2.74 | 3.47 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 10.64% | 0.71% | 3.61% | 2.86% | 11.41% | 16.38% | 33.97% | 22.63% | |
-0.65 | 0.35 | 0.17 | 0.16 | 0.43 | 1.40 | 0.80 | 1.03 | 1.64 | 3.37 | 2.43 | 2.12 | 2.52 | |
EPS in Rs | -1.44 | 0.78 | 0.33 | 0.26 | 0.67 | 2.17 | 1.24 | 1.60 | 2.55 | 5.24 | 3.78 | 3.29 | 3.91 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 62.52% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 18% |
5 Years: | 13% |
3 Years: | 13% |
TTM: | 48% |
Compounded Profit Growth | |
---|---|
10 Years: | 19% |
5 Years: | 22% |
3 Years: | 9% |
TTM: | 8% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 15% |
3 Years: | -15% |
1 Year: | -3% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 18% |
3 Years: | 19% |
Last Year: | 13% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.50 | 4.50 | 5.20 | 6.10 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 | 6.44 |
Reserves | -2.45 | -2.09 | -1.73 | -1.39 | -0.88 | 0.53 | 1.33 | 2.36 | 3.35 | 6.73 | 9.16 | 11.28 | 11.73 |
2.02 | 2.22 | 0.00 | 0.09 | 0.08 | 1.91 | 1.77 | 0.16 | 1.12 | 0.93 | 0.04 | 0.02 | 0.01 | |
0.39 | 0.33 | 2.03 | 1.20 | 0.98 | 2.63 | 1.56 | 1.84 | 2.23 | 3.13 | 3.69 | 3.96 | 4.77 | |
Total Liabilities | 4.46 | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 22.95 |
3.41 | 3.48 | 3.87 | 3.66 | 3.31 | 3.53 | 3.58 | 3.57 | 3.31 | 3.88 | 5.00 | 4.58 | 6.03 | |
CWIP | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.34 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
1.05 | 1.47 | 1.63 | 2.34 | 3.31 | 7.98 | 7.52 | 7.23 | 9.83 | 13.01 | 14.33 | 17.12 | 16.92 | |
Total Assets | 4.46 | 4.96 | 5.50 | 6.00 | 6.62 | 11.51 | 11.10 | 10.80 | 13.14 | 17.23 | 19.33 | 21.70 | 22.95 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.49 | 0.00 | 0.38 | 0.38 | -0.69 | 0.11 | 2.64 | -0.36 | 4.46 | -0.70 | 2.51 | |
0.00 | -0.30 | 0.00 | -0.40 | -0.16 | -1.95 | 0.14 | -0.31 | -0.71 | -2.09 | 0.07 | 0.06 | |
0.00 | 0.19 | 0.00 | 0.11 | 0.01 | 2.06 | -0.42 | -1.60 | 0.32 | 0.32 | -1.20 | -0.53 | |
Net Cash Flow | 0.00 | 0.38 | 0.00 | 0.08 | 0.23 | -0.58 | -0.18 | 0.74 | -0.74 | 2.69 | -1.83 | 2.04 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 4.71 | 11.65 | 28.14 | 12.84 | 27.72 | 100.52 | 139.06 | 94.88 | 182.37 | 87.88 | 131.22 | 136.67 |
Inventory Days | 261.85 | 142.99 | 143.08 | 218.30 | 143.24 | 115.92 | 202.88 | 149.49 | 92.38 | 64.09 | 106.83 | 141.55 |
Days Payable | 214.24 | 101.60 | 90.52 | 108.28 | 81.70 | 84.18 | 36.13 | 46.29 | 58.58 | 22.10 | 57.67 | 78.93 |
Cash Conversion Cycle | 52.32 | 53.04 | 80.70 | 122.86 | 89.26 | 132.26 | 305.81 | 198.08 | 216.16 | 129.86 | 180.37 | 199.29 |
Working Capital Days | 68.29 | 46.60 | 58.69 | 58.60 | 53.76 | 111.74 | 178.80 | 114.54 | 183.17 | 82.01 | 163.43 | 193.47 |
ROCE % | -12.36% | 8.28% | 4.20% | 4.11% | 9.20% | 20.39% | 11.62% | 13.51% | 20.84% | 33.11% | 26.36% | 18.75% |
Documents
Announcements
- Closure of Trading Window 13m
- Revised Financial Results For The Quarter And Nine Months Ended On 31.12.2023 5 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Feb - Dear Sir/Mam, Pursuant to Reg 47 of SEBI (LODR) Regulations, 2015 please find attached herewith a copy of the newspaper publication "Extract of Standalone Un-audited …
- Un-Audited Results For The Quarter And Nine Months Ended On 31.12.2023 14 Feb
- Board Meeting Outcome for Board Meeting Outcome For Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2023 14 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Profile:
a) Beverages:[1]
Ojasvita - Chocolate, Malt, Strawberry, Mango, Golden Latte, etc.
b) Supplements:[2]
Turmeric Plus, Amla, Yastimadhu, Triphala, Nishamlaki, Arjuna
c) Arkas:[3]
Shakti Drops, Tulsi Araka, Ajamoda Arka
d) Single Herbs:[4]
Shakhpushpi, Shatavari, Tulsi, Neem, Brahmi, Ashwagandha, Amrut, Kalamegh, Haritaki
e) Churnas:[5]
Sitophaladi, Hingvastaka, Triphala